In this episode of “Answers From the Lab,” host and William Morice II, M.D., Ph.D., discuss what’s causing recent outbreaks of norovirus and how to keep yourself protected from this leading cause of foodborne illness in the United States.
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and characterize patients’ marijuana use.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Morice and Dr. Pritt discuss laboratory medicine from an international perspective: what advances are being made, how we educate future practitioners, and the need for global collaboration.
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Cori Berg, M.S.N., R.N., instructor in nursing for the Center for Individualized[...]
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, sits down with Joaquin Garcia, M.D., chair of Mayo Clinic’s Division of Anatomic Pathology and digital pathology program to discuss how the advent of digital pathology is changing patient care at Mayo Clinic.
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., provide an update on this year’s triple-demic of respiratory viruses, discuss the future of at-home testing, and preview future pandemic preparedness efforts.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Jennifer Storlie, operations manager of Inpatient Laboratory Services at Mayo Clinic in Rochester, Minnesota, to talk about workforce stability and strategies for retention.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Morice shares his biggest takeaways from this year’s J.P. Morgan Healthcare Conference in San Francisco, California, and gives an update on the COVID-19 public health emergency.
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of eosinophil-derived neurotoxins.
In this episode of Mayo Clinic Laboratories “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, and Shannon Bennett, director of regulatory affairs for Mayo Clinic’s Department of Laboratory Medicine and Pathology, discuss the regulatory environment, its impact on outreach laboratories, and how lab staff can best stay on top of changing laboratory regulations.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, they kick off the new year with a legislative update and discuss at-home testing options in the wake of the new subvariant of COVID-19.